false
0001934064
NASDAQ
NASDAQ
0001934064
2024-05-16
2024-05-16
0001934064
us-gaap:CommonStockMember
2024-05-16
2024-05-16
0001934064
osa:WarrantseachwholewarrantexercisableforoneshareofCommonStockMember
2024-05-16
2024-05-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 16, 2024
ProSomnus, Inc.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-41567 |
|
88-2978216 |
(State or other jurisdiction
of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S Employer
Identification No.) |
5675
Gibraltar Drive
Pleasanton, California 94588
(Address of principal executive offices)
(zip code)
Registrants telephone number, including area code: (844) 537-5337
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | |
Trading
Symbol(s) | |
Name of
each exchange on
which registered |
Common Stock, par value $0.0001 per share | |
OSA(1) | |
(1) |
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share | |
OSAAW(1) | |
(1) |
(1) On April 24, 2024, the Nasdaq Stock Market LLC filed a Form 25 to delist the Company’s common stock and warrants and remove
such securities from registration under Section 12(b) of the Securities Exchange Act of 1934, as amended, which became effective 10 days
after the filing of the Form 25. Effective April 18, 2024, the Company’s common stock and warrants have been traded on the over-the-counter market under the symbols “OSAP” and
“OSAPW”, respectively.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02. Results of Operations and Financial Condition.
On May 16, 2024, ProSomnus, Inc. (“ProSomnus” or the
“Company”) issued a press release announcing its revenue for the three-month period ended March 31, 2024. A copy of the press
release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.
The information contained in Item 2.02 of this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall
not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01. Financial Statements and Exhibits.
d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PROSOMNUS, INC. |
|
|
|
|
Date: May 16, 2024 |
By: |
/s/ Brian B. Dow |
|
|
Name: Brian B. Dow |
|
|
Title: Chief Financial Officer |
Exhibit 99.1
ProSomnus Announces
Strong First Quarter 2024 Revenue Growth
ProSomnus Records
28% Year-Over-Year Revenue Growth Accompanied by Continued Strong Customer Satisfaction
PLEASANTON, Calif.,
May 16, 2024 (GLOBE NEWSWIRE) – ProSomnus, Inc. (the
“Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, today announced results for the first quarter ended
March 31, 2024.
| ● | Revenue
for the first quarter of 2024 totaled $7.5 million, an increase of $1.7 million or 28% compared
to $5.8 million for the first quarter of 2023 representing one of the highest growth rates
in sleep medicine. |
| ● | Industry
leading six-day turnaround with on-time customer deliveries continuing above 99%. |
| ● | RPMO2
Next Generation Remote Patient Monitoring device scheduled for expected final clinical
testing before FDA submission during June 2024. |
"These
exceptional results demonstrate ProSomnus's value proposition, differentiation, and the quality of our people, providers, and processes,"
said Len Liptak, Chief Executive Officer. "To generate top tier revenue growth and make significant progress on our strategic initiatives,
all while going through a restructuring, is truly an outstanding achievement.”
On
May 7, 2024, ProSomnus entered into a voluntary restructuring under Chapter 11 of the U.S. Bankruptcy Code, the terms of which were designed
to enable the Company to maintain normal business operations for customers and suppliers during and after this restructuring process.
The restructuring plan is expected to provide an aggregate of $20 million of new capital, reduce the outstanding senior and subordinate
secured debt by approximately 60%, and result in the Company returning to operating as a private company. The Company expects customers
to continue experiencing predictable turn-around times and on-time order fulfillment, continued exceptional device quality and performance,
and prompt and responsive levels of customer service.
About
ProSomnus
ProSomnus
is the leading non-CPAP therapy TM for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over
1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and
type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient.
Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall
outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by
commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200
million covered lives. To learn more, visit www.ProSomnus.com.
Additional
Information
Filings and other
information related to the Company’s Chapter 11 restructuring case are available on a separate website administrated by the Company’s
claims agent, at www.kccllc.net/prosomnus.
Forward-Looking
Statements
This
Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act. Forward-looking statements generally relate to future events. In some cases, you can identify forward-looking statements because
they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,”
“could,” “intends,” “target,” “projects,” “contemplates,” “believes,”
“estimates,” “predicts,” “potential” or “continue” or the negative of these words or
other similar terms or expressions that concern the proposed transaction and the Company’s expectations, strategy, plans or intentions
regarding it. Forward-looking statements in this press release include, but are not limited to, statements regarding the Company’s
continued operation of the business; the Company’s expectations regarding the anticipated restructuring; including the terms of
the plan, implementation of the plan, the effects of such plan, and amounts of funding received by the Company pursuant to such plan;
the Company’s expectations regarding the timing of the restructuring and the sufficiency of liquidity to complete the restructuring;
and the Company’s operations post-restructuring.
All
forward-looking statements included in this press release are made as of the date of this release, based on information currently available
to the Company, deal with future events, and are subject to various risks and uncertainties, including the risk that the Company’s
ability to fund its planned operations for the next twelve months and its ability to continue as a going concern; the adverse impact
of the restructuring on the Company’s business, financial condition, and results of operations; the Company’s ability to
successfully consummate the restructuring and emerge from the restructuring process, including by entering into and ultimately completing
the restructuring; the Company’s ability to improve its liquidity and long-term capital structure and to address its debt service
obligations through the restructuring; the Company’s ability to make the required payments under the agreements governing its current
debt obligations; the Company’s ability to maintain relationships with suppliers, customers, employees and other third parties
as a result of the restructuring; the effects of the restructuring on the Company and the interests of various constituents; risks and
uncertainties associated with the restructuring, including the Company’s ability to receive approvals for the various elements
of the restructuring, obtain confirmation of the restructuring plan and successfully consummate the restructuring; and the Company’s
ability to receive any required approvals of the restructuring plan and the responses of its securityholders and other stakeholders,
including those party to any potential financing, among other risks and uncertainties, and actual results could differ materially from
those anticipated in those forward-looking statements. The risks and uncertainties that may cause actual results to differ materially
from the Company’s current expectations are more fully described in the Company’s Annual Report on Form 10-K filed with the
SEC on March 27, 2024 and the amendment thereto filed on April 29, 2024, any subsequently filed Quarterly Reports on Form 10-Q, and its
other reports, each as filed with the SEC. Except as required by law, the Company assumes no obligation to update any such forward-looking
statement after the date of this Current Report or to conform these forward-looking statements to actual results.
Investor
Contact
Mike Cavanaugh
ICR Westwicke
Phone: +1.617.877.9641
Email: Mike.Cavanaugh@westwicke.com
Media Contact
Heather Whalen
ProSomnus
Phone: +1.925.360.2990
Email: HWhalen@ProSomnus.com
v3.24.1.1.u2
Cover
|
May 16, 2024 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
May 16, 2024
|
Entity File Number |
001-41567
|
Entity Registrant Name |
ProSomnus, Inc.
|
Entity Central Index Key |
0001934064
|
Entity Tax Identification Number |
88-2978216
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
5675
Gibraltar Drive
|
Entity Address, City or Town |
Pleasanton
|
Entity Address, State or Province |
CA
|
Entity Address, Postal Zip Code |
94588
|
City Area Code |
844
|
Local Phone Number |
537-5337
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Common Stock [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Common Stock, par value $0.0001 per share
|
Trading Symbol |
OSA(1)
|
Security Exchange Name |
NASDAQ
|
Warrantseachwholewarrantexercisableforoneshareof Common Stock [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
|
Trading Symbol |
OSAAW(1)
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=osa_WarrantseachwholewarrantexercisableforoneshareofCommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
ProSomnus (PK) (USOTC:OSAPW)
Historical Stock Chart
From May 2024 to Jun 2024
ProSomnus (PK) (USOTC:OSAPW)
Historical Stock Chart
From Jun 2023 to Jun 2024